The rise of Sildenafil initially fueled a surge for pharma, but recent shifts present a uncertain picture for those considering a stake. Off-patent versions are eating into profits, and ongoing patent challenges add https://tiffanygmbq802176.59bloggers.com/41527055/viagra-and-pharma-a-precarious-bet